Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Green Bay › NPI 1114908001
Hospital

ST Vincent Hospital-Hospital Sisters-Third Order of ST Francis

ST Vincent Hospital-Hospital Sisters-Third Order of ST Francis was paid $19.54M by Medicaid between Jan 2018 and Dec 2024, across 274 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.

33Billing provider infoST VINCENT HOSPITAL-HOSPITAL SISTERS-THIRD ORDER OF ST FRANCIS
GREEN BAY, WI 54301
33aNPI1114908001assigned 11/08/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.54M
24GClaims822,965
24DCodes billed274
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#9 of 60
Median peer was paid$2.90M
This provider vs. median6.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018105,022$2.68M
2019116,455$2.91M
2020110,577$2.58M
2021125,548$2.76M
2022137,131$2.96M
2023132,848$3.09M
2024incomplete95,384$2.57M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 34,305 30,484 $2.46M
96361 Intravenous infusion, hydration; each additional hour 9.7% 13,738 10,666 $1.90M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.2% 25,762 22,332 $1.40M
80053 Comprehensive metabolic panel 6.0% 39,595 31,184 $1.18M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.5% 10,601 9,634 $874K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.9% 10,854 6,152 $762K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.6% 13,885 12,119 $704K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2.5% 5,115 4,201 $488K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2.4% 1,634 1,461 $476K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 51,222 38,134 $444K
29581 2.1% 8,632 1,890 $413K
70450 Computed tomography, head or brain; without contrast material 2.1% 6,172 5,429 $412K
262 more codes
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.0% 8,673 $390K
99214 Doctor's office visit, returning patient (more involved) 1.9% 6,290 $379K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 5,506 $375K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 5,539 $274K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.3% 4,462 $249K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.2% 2,661 $241K
G0378 Hospital observation service, per hour 1.2% 4,661 $240K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.2% 4,573 $230K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.1% 4,569 $218K
99213 Doctor's office visit, returning patient (routine) 1.1% 3,246 $216K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 5,912 $210K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.0% 4,634 $203K
80048 Basic metabolic panel (calcium, ionized) 1.0% 8,297 $202K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,920 $188K
80306 <1% 4,231 $187K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,410 $179K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 889 $163K
99215 Doctor's office visit, returning patient (complex) <1% 1,677 $148K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,211 $141K
81025 <1% 10,631 $136K
59025 Fetal non-stress test <1% 1,718 $126K
81001 <1% 21,574 $120K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,827 $117K
84484 <1% 11,325 $114K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,806 $112K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,986 $110K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,842 $108K
96367 <1% 1,943 $105K
87430 <1% 3,571 $103K
87081 <1% 2,330 $101K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,527 $97K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,809 $97K
97597 <1% 2,707 $81K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 595 $81K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,958 $76K
82728 <1% 3,264 $65K
87210 <1% 2,485 $60K
96415 <1% 718 $58K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 8,651 $58K
72125 Computed tomography, cervical spine; without contrast material <1% 2,399 $57K
70496 <1% 927 $57K
83690 <1% 9,905 $55K
87077 <1% 3,153 $54K
87070 <1% 1,685 $52K
87486 <1% 1,631 $52K
70498 <1% 909 $51K
93971 <1% 1,344 $45K
87581 <1% 1,631 $44K
84702 <1% 1,426 $40K
36430 <1% 364 $40K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 19,583 $39K
G0379 Direct admission of patient for hospital observation care <1% 908 $37K
83735 <1% 6,511 $35K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 534 $34K
87040 <1% 5,237 $34K
86850 <1% 2,914 $32K
85610 <1% 6,187 $31K
83605 <1% 4,306 $31K
96375 Therapeutic injection; each additional sequential IV push <1% 16,261 $31K
70551 Magnetic resonance imaging, brain; without contrast material <1% 435 $30K
82565 <1% 1,904 $30K
83880 <1% 1,586 $29K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 484 $28K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,540 $28K
94664 <1% 1,652 $28K
93017 <1% 812 $26K
85027 <1% 2,878 $25K
12001 <1% 306 $25K
85379 <1% 3,005 $25K
87807 <1% 1,172 $25K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 266 $23K
41899 Unlisted procedure, dentoalveolar structures <1% 47 $23K
84145 <1% 1,438 $23K
71046 Radiologic examination, chest; 2 views <1% 4,049 $22K
87186 <1% 2,947 $20K
95806 <1% 482 $18K
84443 Thyroid stimulating hormone (TSH) <1% 1,669 $17K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 82 $16K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 38 $15K
0042T <1% 362 $15K
86140 <1% 3,463 $13K
85730 <1% 3,344 $12K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 276 $12K
78815 Positron emission tomography (PET) for limited area imaging <1% 42 $12K
87088 <1% 2,127 $11K
76830 Ultrasound, transvaginal <1% 245 $11K
80076 <1% 490 $10K
72141 <1% 140 $9K
12011 <1% 72 $8K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 12 $8K
86900 <1% 3,234 $8K
29125 <1% 122 $8K
84100 <1% 2,197 $8K
82805 <1% 313 $8K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 89 $8K
80050 General health panel <1% 2,170 $8K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 18 $7K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 41 $7K
86901 <1% 3,236 $7K
71045 Radiologic examination, chest; single view <1% 11,634 $7K
84132 <1% 369 $7K
36902 <1% 28 $6K
86923 <1% 222 $6K
96409 <1% 347 $6K
83550 <1% 1,125 $6K
85652 <1% 3,130 $6K
93458 <1% 12 $5K
95800 <1% 114 $5K
70486 <1% 145 $5K
90715 <1% 758 $5K
83540 <1% 1,167 $5K
97605 <1% 67 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,200 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 306 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 41 $4K
71250 <1% 134 $4K
84439 <1% 293 $4K
80061 Lipid panel <1% 298 $4K
82550 <1% 683 $3K
89051 <1% 38 $3K
74018 <1% 1,127 $3K
84703 <1% 301 $3K
90686 <1% 273 $3K
93922 <1% 98 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 293 $3K
93225 <1% 99 $2K
85007 <1% 150 $2K
95700 <1% 12 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 13 $2K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 52 $2K
76770 <1% 33 $2K
72197 <1% 14 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 29 $1K
96417 <1% 61 $1K
82784 <1% 132 $1K
73630 <1% 1,618 $1K
12002 <1% 17 $1K
70491 <1% 16 $1K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 13 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,439 $1K
93970 <1% 27 $960.80
96523 <1% 13 $926.40
83615 <1% 135 $889.54
72100 <1% 378 $883.36
86308 <1% 30 $807.61
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 673 $790.35
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 25 $664.40
85045 <1% 203 $624.82
G0008 Administration of influenza virus vaccine <1% 319 $555.20
93226 <1% 99 $447.03
96376 <1% 3,026 $433.79
73610 <1% 1,046 $416.15
99152 <1% 2,473 $402.25
88307 <1% 232 $378.23
87075 <1% 89 $360.41
82272 <1% 42 $355.01
82607 <1% 59 $333.25
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 13 $288.96
J7030 Infusion, normal saline solution , 1000 cc <1% 25,702 $284.46
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 760 $279.82
36415 Collection of venous blood by venipuncture <1% 7,387 $265.09
82570 <1% 51 $223.80
76870 <1% 13 $221.25
87205 <1% 78 $217.47
82150 <1% 41 $217.10
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 21 $180.48
84156 <1% 56 $179.47
36591 <1% 853 $159.64
82009 <1% 49 $150.84
72170 <1% 376 $144.16
86780 <1% 13 $140.01
76937 <1% 87 $109.38
73030 <1% 756 $103.29
90656 <1% 13 $90.39
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 608 $75.48
J3490 Unclassified drugs <1% 16,787 $71.26
84550 <1% 14 $63.52
73562 <1% 825 $58.50
85018 <1% 29 $47.45
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,426 $46.43
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 16,925 $43.51
74019 <1% 134 $42.61
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 545 $41.02
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 1,417 $41.01
88304 <1% 271 $24.95
97535 Self-care/home management training, each 15 minutes <1% 28 $20.93
72040 <1% 15 $18.44
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,707 $18.23
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 3,400 $17.36
73140 <1% 43 $16.88
A9270 Non-covered item or service <1% 3,841 $13.27
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,945 $12.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 11,306 $10.43
88312 <1% 741 $9.81
J3010 Injection, fentanyl citrate, 0.1 mg <1% 13,028 $9.41
J1170 Injection, hydromorphone, up to 4 mg <1% 4,457 $9.06
73502 <1% 137 $8.64
73130 <1% 495 $8.44
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 18,853 $8.42
88313 <1% 151 $7.83
99153 Mod sedat endo service >5yrs <1% 1,764 $7.33
J2550 Injection, promethazine hcl, up to 50 mg <1% 161 $6.39
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,901 $5.37
88342 <1% 26 $5.37
J7120 Ringers lactate infusion, up to 1000 cc <1% 9,440 $5.16
C1729 Catheter, drainage <1% 65 $3.44
C1769 Guide wire <1% 2,200 $3.37
J2704 Injection, propofol, 10 mg <1% 13,347 $2.51
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 94 $2.50
J1650 Injection, enoxaparin sodium, 10 mg <1% 616 $2.00
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 672 $1.95
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,037 $1.63
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,653 $1.47
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 154 $0.92
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 298 $0.72
J0736 Injection, clindamycin phosphate, 300 mg <1% 51 $0.70
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,437 $0.30
J1644 Injection, heparin sodium, per 1000 units <1% 3,058 $0.21
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 478 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 1,071 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 3,899 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 346 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 693 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 883 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 534 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 6,287 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 191 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 353 $0.00
J2060 Injection, lorazepam, 2 mg 0% 1,533 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 193 $0.00
71101 0% 44 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 17 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 60 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 248 $0.00
36416 0% 165 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 92 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 16 $0.00
80349 0% 16 $0.00
94644 0% 16 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 814 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 186 $0.00
J9370 Vincristine sulfate, 1 mg 0% 97 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 2,262 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 787 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 154 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 210 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 783 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 0% 107 $0.00
73110 0% 294 $0.00
73080 0% 86 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 262 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 73 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 272 $0.00
73590 0% 82 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 233 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 44 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 27 $0.00
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 0% 55 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 33 $0.00
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf 0% 41 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 29 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALLEN, PATTY (CFO)
Same official

Other billing entities under ALLEN, PATTY

Full network →
ProviderLocationPaid
Greenville RancheriaGreenville, CA$4.12M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.